Grifols Partners with BARDA to Develop Treatment for Sulfur Mustard Ocular Injury
Grifols (BME: GRF; NASDAQ: GRFS), a Spanish biopharmaceutical company, has announced a partnership with the...
NASDAQ: GRFS
Grifols Completes Sale of 20% Stake in Shanghai RAAS to Haier Group for RMB 12.5 Billion
Grifols AS (NASDAQ: GRFS), a Spain-based global leader in the production of blood products, has...
Grifols Sells 20% Stake in Shanghai RAAS to Haier Group for USD 1.8 Billion
Grifols (BME: GRF; NASDAQ: GRFS), a Spanish pharmaceutical company, has announced the formation of an...
Grifols AS Plans to Sell Stake in Shanghai RAAS Blood Products Co., Ltd for Up to $1.5 Billion
Spain-based Grifols AS (NASDAQ: GRFS), a leading global player in the blood products industry, has...